Oliver Sutcliffe graduated from the University of Liverpool, Liverpool, UK, with a B.S. degree with honors in chemical sciences in 1996. He subsequently obtained a Ph.D. degree in synthetic organic chemistry working on ̋New Extended Dipolar Systems̏ under Drs. R.C. Storr and T.L. Gilchrist from the same institution. In 1999, he joined Professor M. R. Bryce’s group at the University of Durham as a PDRF investigating the application of enantiopure ferrocene ligands in asymmetric synthesis. He then moved to industry and worked as a Medicinal Chemist on the design, development, and optimisation of drug molecules for a broad-range of biological targets, including cancer. He moved to the University of Strathclyde in 2006, obtained an M.S. degree in pharmaceutical analysis, and after a period at the European Directorate for the Quality of Medicines and Healthcare (EDQM) in Strasbourg was appointed as a Lecturer in the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS). In January 2012, Dr. Sutcliffe joined the staff at Manchester Metropolitan University as a Lecturer in Pharmaceutical and Analytical Chemistry. Dr. Sutcliffe’s research interests include: (1) the synthesis, profiling (chemical, biological, and metabolic), and development of methods for the detection/quantification of ̋legal highs̏ such as mephedrone (and its derivatives); (2) the development of simple, rapid, and selective presumptive tests (in collaboration with Professor Niamh Nic Daeid, Centre for Forensic Science, University of Strathclyde) which can be easily applied by ̋non-specialists̏ for the detection of illicit substances in the field; and (3) anticancer drug design, development, and optimisation with Dr. Nial J. Wheate (University of Sydney, Australia), collaborators in SIPBS and the Beatson Institute for Cancer Research in Glasgow.
Biography Updated on 2 August 2012